نتایج جستجو برای: biomarker screening

تعداد نتایج: 282581  

Journal: :journal of paramedical sciences 0
naser nejadi proteomics research center, faculty of paramedical sciences, shahidbeheshti university of medical sciences, tehran, iran sedigheh hantoushzadeh department of obstetrics and gynecology, faculty of medicine, tehran university of medical sciences, tehran, iran setareh mohammadpoor masti proteomics research center, faculty of paramedical sciences, shahidbeheshti university of medical sciences, tehran, iran zohreh sadat hosseini proteomics research center, faculty of paramedical sciences, shahidbeheshti university of medical sciences, tehran, iran masoumea mousavi proteomics research center, faculty of paramedical sciences, shahidbeheshti university of medical sciences, tehran, iran sattar gorgani-firuzjaee department of biochemistry, faculty of medicine, aja university of medical sciences, tehran, iran

the aim of this investigation was conducted to proteomic analysis of plasma obtained from pregnant women who destined to develop late-onset preeclampsia without intrauterine growth restriction (iugr) during 16 th week of gestation. plasma was obtained from primiparous women during 16 th week of gestation. 2-de proteomic analysis was done for plasma from 11 healthy pregnant women and 11 women wh...

2011
Andrew W. Browne Jennifer L. Leddon Mark A. Currier Jon P. Williams Jason S. Frischer Margaret H. Collins Chong H. Ahn Timothy P. Cripe

Cancer biomarkers facilitate screening and early detection but are known for only a few cancer types. We demonstrated the principle of inducing tumors to secrete a serum biomarker using a systemically administered gene delivery vector that targets tumors for selective expression of an engineered cassette. We exploited tumor-selective replication of a conditionally replicative Herpes simplex vir...

Journal: :Biostatistics 2003
Martin W McIntosh Nicole Urban

A revolution in molecular technology is leading to the discovery of many biomarkers of disease. Monitoring these biomarkers in a population may lead to earlier disease detection, and may prevent death from diseases like cancer that are more curable if found early. For markers whose concentration is associated with disease progression the earliest detection is achieved by monitoring the marker w...

Journal: :Alcohol and alcoholism 2004
Peter M Miller Steven M Ornstein Paul J Nietert Raymond F Anton

AIMS To assess knowledge and use of alcohol self-report and biomarker screening by physicians. METHODS Forty-eight primary care physicians were surveyed. RESULTS Knowledge of MCV and GGT was as good as that for non-biomarker screening tools (CAGE, AUDIT) although use was significantly less. Knowledge and use of carbohydrate-deficient transferrin (CDT) was extremely low. CONCLUSIONS Little...

2016
Eline Schreuders

Colorectal cancer (CRC) forms an important public health problem, especially in developed countries. CRC screening tests can be used to identify asymptomatic individuals with CRC pre-cursors and (early) cancer. Removal of these lesions reduces CRC incidence and prevents CRC related mortality. There are a range of screening tests available, each with advantages and disadvantages. Stool screening...

Cardiovascular disease (CVD) is a leading cause of death worldwide and continues to increase in prevalence compared to previous decades, in part because of the aging of the world population. Atherosclerotic CVD starts at a very young age and progresses over time allowing sufficient time for screening and early detection of the condition. Advances in biomarker research and developments related t...

Journal: :Annals of oncology : official journal of the European Society for Medical Oncology 2016
M J Overman V Morris B Kee D Fogelman L Xiao C Eng A Dasari R Shroff T Mazard K Shaw E Vilar K Raghav I Shureiqi L Liang G B Mills R A Wolff S Hamilton F Meric-Bernstam J Abbruzzese J Morris D Maru S Kopetz

BACKGROUND Incorporation of multiple enrichment biomarkers into prospective clinical trials is an active area of investigation, but the factors that determine clinical trial enrollment following a molecular prescreening program have not been assessed. PATIENTS AND METHODS Patients with 5-fluorouracil-refractory metastatic colorectal cancer at the MD Anderson Cancer Center were offered screeni...

2016
Eline H. Schreuders Esmée J. Grobbee Manon C. W. Spaander Ernst J. Kuipers

OPINION STATEMENT Colorectal cancer (CRC) forms an important public health problem, especially in developed countries. CRC screening tests can be used to identify asymptomatic individuals with CRC precursors and (early) cancer. Removal of these lesions reduces CRC incidence and prevents CRC-related mortality. There are a range of screening tests available, each with advantages and disadvantages...

2014
Usha Menon Michelle Griffin Aleksandra Gentry-Maharaj

Evidence of a mortality benefit continues to elude ovarian cancer (OC) screening. Data from the US Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial which used a screening strategy incorporating CA125 cut-off and transvaginal ultrasound has not shown mortality benefit. The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) is using the Risk of Ovarian Ca...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید